Copyright
©The Author(s) 2022.
World J Clin Cases. Jan 14, 2022; 10(2): 485-491
Published online Jan 14, 2022. doi: 10.12998/wjcc.v10.i2.485
Published online Jan 14, 2022. doi: 10.12998/wjcc.v10.i2.485
Table 3 Magnetic resonance imaging-related examination parameters (mean ± SD)
| Group | T-wave peak | Apparent diffusion coefficient | Peak enhancement rate | Early enhancement rate |
| Breast cancer (n = 63) | 169.43 ± 32.05 | 1.01 ± 0.23 | 1.08 ± 0.24 | 1.07 ± 0.26 |
| Benign tumor (n = 63) | 228.86 ± 46.51 | 1.41 ± 0.35 | 0.83 ± 0.19 | 0.75 ± 0.19 |
| t value | 8.351 | 7.581 | 6.482 | 7.887 |
| P value | 0.000 | 0.000 | 0.000 | 0.000 |
- Citation: Gu WQ, Cai SM, Liu WD, Zhang Q, Shi Y, Du LJ. Combined molybdenum target X-ray and magnetic resonance imaging examinations improve breast cancer diagnostic efficacy. World J Clin Cases 2022; 10(2): 485-491
- URL: https://www.wjgnet.com/2307-8960/full/v10/i2/485.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i2.485